A potent inhibitor of neurite outgrowth that predominates in the extracellular matrix of reactive astrocytes

International Journal of Developmental Neuroscience

Volumn 14, Issue 3, 1996, Pages 153-175

  Canning, David R ^a   Höke, Ahmet ^a   Malemud, Charles J ^a   Silver, Jerry ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chondroitin sulphate; CNS; Gliosis; Proteoglycan; Regeneration

Indexed keywords

AMYLOID BETA PROTEIN; CHONDROITIN SULFATE; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ASTROCYTE; ASTROCYTOSIS; BIOLOGICAL MODEL; EXTRACELLULAR MATRIX; NERVE CELL CULTURE; NEURITE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALIA;

EID: 0030175404     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/0736-5748(96)00004-4     Document Type: Article

References (97)

1. Aguayo A. J., Bjorklund A., Stenevi U., Carlstedt T. Fetal mesencephalic neurons survive and extend long axons across peripheral nervous system grafts inserted into the adult rat striatum. Neurosci. Lett. 45:1984;53-58.
2. Aguayo A. J., Bray G. M., Rasminsky M., Zwimpfer T., Carter D., Vidal S. M. Synaptic connections made by axons regenerating in the central nervous system of adult mammals. J. exp. Biol. 153:1990;199-224.
3. Aguayo A. J., David S., Bray G. M. Influences of the glial environment on the elongation of axons after injury: transplantation studies in adult rodents. J. exp. Biol. 95:1981;231-240.
4. Andres J. L., DeFalcis D., Noda M., Massague J. Binding of two growth factor families to separate domains of the proteoglycan betaglycan. J. biol. Chem. 267:1992;5927-5930.
5. Andres J. L., Ronnstrand L., Cheifetz S., Massague J. Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan. J. biol. Chem. 266:1991;23282-23287.
6. Andres J. L., Stanley K., Cheifetz S., Massague J. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J. Cell Biol. 109:1989;3137-3145.
7. Ard M. D., Bunge R. P. Heparan sulfate proteoglycan and laminin immunoreactivity on cultured astrocytes: relationship to differentiation and neurite growth. J. Neurosci. 8:1988;2844-2858.
8. Argiro V., Bunge M. B., Johnson M. I. Correlation between growth form and movement and their dependence on neuronal age. J. Neurosci. 4:1984;3051-3062.
9. Asher R., Bignami A. Localization of hyaluronate in primary glial cell cultures derived from newborn rat brain. Expl Cell Res. 195:1991;401-411.
10. Avnur Z., Geiger B. Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell. 38:1984;811-822.
11. Benes F. M., Reifel J. L., Majocha R. E., Marotta C. A. Evidence for a diffusional model of Alzheimer amyloid A4 (beta-amyloid) deposition during neuritic plaque formation. Neuroscience. 33:1989;483-488.
12. Bernfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. A. Rev. Cell Biol. 8:1992;365-393.
13. Bignami A., Hosley M., Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat. Embryol., Berlin. 188:1993;419-433.
14. Bitter T., Muir H. M. A modified uronic acid carbazole reaction. Analyt. Biochem. 4:1962;330-334.
15. Bovolenta P., Wandosell F., Nieto S. M. CNS glial scar tissue: a source of molecules which inhibit central neurite outgrowth. Prog. Brain Res. 94:1992;367-379.
16. Bovolenta P., Wandosell F., Nieto S. M. Neurite outgrowth inhibitors associated with glial cells and glial cell lines. Neuroreport. 5:1993;345-348.
17. Bovolenta P., Wandosell F., Nieto-Sampedro M. Characterization of a neurite outgrowth inhibitor expressed after CNS injury. Eur. J. Neurosci. 5:1993;454-465.
18. Brittis P., Canning D. R., Silver J. Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science. 255:1992;733-736.
19. Canning D. R., McKeon R. J., DeWitt D. A., Perry G., Wujek J. R., Frederickson R. C., Silver J. beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Expl Neurol. 124:1993;289-298.
20. Carpenter M. K., Crutcher K. A., Kater S. B. An analysis of the effects of Alzheimer's plaques on living neurons. Neurobiol. Aging. 14:1993;207-215.
21. Cole G. J., McCabe C. F. Identification of a developmentally regulated keratan sulfate proteoglycan that inhibits cell adhesion and neurite outgrowth. Neuron. 7:1991;1007-1018.
22. Cotman C., Pike C. J., Copani A. beta-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging. 13:1992;587-590.
23. Couchman J. R., Caterson B., Christner J. E., Baker J. R. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature. 307:1984;650-652.
24. Damon D. H., D'Amore P. A., Wagner J. A. Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells. J. Cell Physiol. 135:1988;293-300.
25. Davies S. J., Field P. M., Raisman G. Long interfascicular axon growth from embryonic neurons transplanted into adult myelinated tracts. J. Neurosci. 12:1994;000.
26. Davis G. E., Klier F. G., Engvall E., Cornbrooks C., Varon S., Manthorpe M. Association of laminin with heparan and chondroitin sulfate-bearing proteoglycans in neurite-promoting factor complexes from rat schwannoma cells. Neurochem. Res. 12:1987;909-921.
27. Dewitt D. A., Richey P. L., Praprotnik D., Silver J., Perry G. Chondroitin sulfate proteolgycans are common components of neuronal inclusion and astrocytic reaction in neurodegenerative diseases. Brain Res. 656:1994;205-209.
28. DeWitt D. A., Silver J., Canning D. R., Perry G. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Expl Neurol. 121:1993;149-152.
29. Dou C.-L., Levine J. M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 12:1994;7616-7628.
30. Dow K. E., Ethell D. W., Steeves J. D., Riopelle R. J. Molecular correlates of spinal cord repair in the embryonic chick: heparan sulfate and chondroitin sulfate proteoglycans. Expl Neurol. 128:1994;233-238.
31. Dow K. E., Guo M., Kisilevsky R., Riopelle R. J. Regenerative neurite growth modulation associated with astrocyte proteoglycans. Brain Res. Bull. 30:1993;461-467.
32. Dow K. E., Levine R. L., Solc M. A., DaSilva O., Riopelle R. J. Axonal transport of proteoglycans in regenerating goldfish optic nerve. Expl Neurol. 126:1994;129-137.
33. Dow K. E., Riopelle R. J., Kisilevsky R. Domains of neuronal heparan sulphate proteoglycans involved in neurite outgrowth on laminin. Cell Tissue Res. 265:1991;345-351.
34. Faissner A., Clement A., Lochter A., Streit A., Mandl C., Schachner M. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J. Cell Biol. 126:1994;783-799.
35. Fawcett J. W., Housden E., Smith T. L., Meyer R. L. The growth of axons in three-dimensional astrocyte cultures. Devl Biol. 135:1989;449-458.
36. Friedlander D. R., Milev P., Karthikeyan L., Margolis R. K., Margolis R. U., Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J. Cell Biol. 125:1994;669-680.
37. Geisert E. E., Bidanset D. J. A central nervous system keratan sulfate proteoglycan-localization to boundaries in the neonatal rat brain. Brain Res. Devl Brain Res. 75:1993;163-173.
38. Grierson J. P., Petroski R. E., Ling D. S., Geller H. M. Astrocyte topography and tenascin cytotactin expression: correlation with the ability to support neuritic outgrowth. Brain Res. Devl Brain Res. 55:1990;11-19.
39. Groves A. K., Entwhistle A., Jat P. S., Noble M. The characterisation of astrocyte cell lines that display properties of glial scar tissue. Devl Biol. 159:1993;97-104.
40. Grumet M., Flaccus A., Margolis R. U. Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. J. Cell Biol. 120:1993;815-824.
41. Grumet M., Milev P., Sakurai T., Karthikeyan L., Bourdon M., Margolis R. K., Margolis R. U. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J. biol. Chem. 269:1994;12142-12146.
42. Hoffman S., Crossin K. L., Edelman G. M. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J. Cell Biol. 106:1988;519-532.
43. Höke A., Canning D. R., Malemud C. J. and Silver J. Regional differences in reactive gliosis induced by substratebound beta amyloid. Expl Neurol., in press.
44. Johnson G. P., Dow K. E., Riopelle R. J. Characterization of glycosaminoglycans produced by primary astrocytes in vitro. Glia. 4:1991;314-321.
45. Kawaja M. D., Gage F. H. Reactive astrocytes are substrates for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor. Neuron. 7:1991;1019-1030.
46. Koo E. H., Park L., Selkoe D. J. Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. natn. Acad. Sci. U.S.A. 90:1993;4748-4752.
47. Kure S., Yoshie O. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformationdependent alteration in cell surface HS-GAG defined by HepSS-1. J. Immun. 137:1986;3900-3908.
48. Lafont F., Rouget M., Triller A., Prochiantz A., Rousselet A. In vivo control of neuronal polarity by glycosaminoglycans. Development. 114:1992;17-29.
49. Levine J. M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14:1994;4716-4730.
50. Li Y., Raisman G. Schwann cells induce sprouting in motor and sensory axons in the adult rat spinal cord. J. Neurosci. 14:1994;4050-4063.
51. Logan A., Berry M., Gonzalez A. M., Frautschy S. A., Sporn M. B., Baird A. Effects of transforming growth factor-β1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6:1994;355-363.
52. Logan A., Frautschy S. A., Gonzalez A. M., Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J. Neurosci. 12:1992;3828-3837.
53. Margolis R. K., Margolis R. U. Nervous tissue proteoglycans. Experientia. 49:1993;429-446.
54. Margolis R. U., Margolis R. K. Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease. Neurobiol. Aging. 10:1989;500-502.
55. McKeon R. J., Höke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Expl. Neurol. 136:1995;32-43.
56. McKeon R. J., Schreiber R. C., Rudge J. S., Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11:1991;3398-3411.
57. McKeon R. J., Silver J. Increased neurite outgrowth on glial scars following enzymatic digestion of chondroitin sulfate proteoglycan. Soc. Neurosci. Abstr. 18:1992;619.
58. Nieto-Sampedro M., Lewis E. R., Cotman C. W., Manthorpe M., Skaper S. D., Barbin G., Longo F. M., Varon S. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science. 217:1982;860-861.
59. Nieto-Sampedro M., Manthrope M., Barbin G., Varon S., Cotman C. W. Injury-induced neuronotrophic activity in adult rat brain: correlation with survival of delayed implants in the wound cavity. J. Neurosci. 3:1983;2219-2229.
60. Nieto-Sampedro M., Saneto R. P., de V. J., Cotman C. W. The control of glial populations in brain: changes in astrocyte mitogenic and morphogenic factors in response to injury. Brain Res. 343:1985;320-328.
61. Oakley R. A., Tosney K. W. Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo. Devl Biol. 147:1991;187-206.
62. Oohira A., Matsui F., Katoh S. R. Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. J. Neurosci. 11:1991;822-827.
63. Oohira A., Matsui F., Matsuda M., Takida Y., Kuboki Y. Occurrence of three distinct molecular species of chondroitin sulfate proteoglycan in the developing rat brain. J. biol. Chem. 263:1988;10240-10246.
64. Pike C. J., Cummings B. J., Monzavi R. and Cotman C. W. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience, in press.
65. Pindzola R. R., Doller C., Silver J. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Devl Biol. 156:1993;34-48.
66. Rapraeger A. C., Krufka A., Olwin B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1991;1705-1708.
67. Rauch U., Gao P., Janetzko A., Flaccus A., Hilgenberg L., Tekotte H., Margolis R. K., Margolis R. U. Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies. J. biol. Chem. 266:1991;14785-14801.
68. Reier P. J. (1986) Gliosis following CNS injury: the anatomy of astrocytic scars and their influences on axonal elongation. In Astrocytes (eds Fedoroff S. and Vernadakis A.), pp. 263-324. Academic Press, Orlando.
69. Reier P. J., Houle J. D. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv. Neurol. 47:1988;87-138.
70. Riopelle R. J., Dow K. E. Functional interactions of neuronal heparan sulphate proteoglycans with laminin. Brain Res. 525:1990;92-100.
71. Rosenberg L. C., Choi H. U., Tang L.-H., Johnson T. L., Pal S., Webber C., Reiner A., Poole A. R. Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J. biol. Chem. 260:1985;6304-6313.
72. Rudge J. S., Silver J. Inhibition of neurite outgrowth on astroglial scars in vitro. J. Neurosci. 10:1990;3594-3603.
73. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
74. Salmivirta M., Heino J., Jalkanen M. Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth. J. biol. Chem. 267:1992;17606-17610.
75. Schwab M. E., Kapfhammer J. P., Bandtlow C. E. Inhibitors of neurite outgrowth. A. Rev. Neurosci. 16:1993;565-595.
76. Shuckett R., Malemud C. J. Qualitative changes in human osteoarthritic hip cartilage proteoglycan synthesis during long-term explant culture. Mech. Ageing Dev. 46:1988;33-45.
77. Smith G. M., Rutishauser U., Silver J., Miller R. H. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Devl Biol. 138:1990;377-390.
78. Smith-Thomas L. C., Fok-Seang J., Stevens J., Du J.-S., Muir E., Faissner A., Geller H. M., Rogers J. H., Fawcwtt J. W. An inhibitor of neurite outgrowth produced by astrocytes. J. Cell Sci. 107:1994;1687-1695.
79. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T. N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Path. 133:1988;456-463.
80. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar A alpha-amyloid in rat brain. Neuron. 12:1994;219-234.
81. Snow A. D., Sekiguchi R. T., Nochlin D., Kalaria R. N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimers disease brain. Am. J. Path. 144:1994;337-347.
82. Snow D. M., Letourneau P. C. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J. Neurobiol. 23:1992;322-336.
83. Snow D. M., Atkinson P. B., Hassinger T. V., Letourneau P. C., Kater S. B. Chondroitin sulphate proteoglycan elevates cytoplasmic calcium in DRG neurons. Devl Biol. 166:1994;87-100.
84. Snow D. M., Steindler D. A., Silver J. Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: a possible role for a proteoglycan in the development of an axon barrier. Devl Biol. 138:1990;359-376.
85. Snow D. M., Watanabe M., Letourneau P. C., Silver J. A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth. Development. 113:1991;1473-1485.
86. Sorrell J. M., Carrino D. A., Caplan A. I. Structural domains in chondroitin sulfate identified by antichondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. Matrix. 13:1993;351-361.
87. Stallcup W. B., Beasley L. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J. Neurosci. 7:1987;2737-2744.
88. Streit A., Nolte C., Rasony T., Schachner M. Interaction of astrochondrin with extracellular matrix components and its involvement in astrocyte process formation and cerebellar granule cell migration. J. Cell Biol. 120:1993;799-814.
89. Timpl R. Proteoglycans of basement membranes. Experientia. 49:1993;417-428.
90. Verna J.-M., Fichard A., Saxod R. Influence of glycosaminoglycans on neurite morphology and outgrowth patterns in vitro. Int. J. Devl Neurosci. 7:1989;389-399.
91. Walicke P. A. Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth. Expl Neurol. 102:1988;144-148.
92. Wang X. F., Lin H. Y., Ng E. E., Downward J., Lodish H. F., Weinberg R. A. Expression, cloning and characterization of the TGF-beta type III receptor. Cell. 67:1991;797-805.
93. Wasteson A. A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J. Chromat. 59:1971;87-97.
94. Yankner B. A., Dawes L. R., Fisher S., Villa K. L., Oster G. M., Neve R. L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
95. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
96. Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
97. Zaremba S., Guimaraes A., Kalb R. G., Hockfield S. Characterization of an activity-dependent, neuronal surface proteoglycan identified with monoclonal antibody Cat-301. Neuron. 2:1989;1207-1219.